Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas J Simmonds

Showing results (31-40 of 68) with videos related to

Pageof 7
Sort By:
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 14, 2025
"Mind the gap"- will we ever see equal median predicted survival for males and females in cystic fibrosis?Jamie Duckers, Sarah L Clarke, Susan C Charman, et al.
Pediatric Pulmonology|January 12, 2021
Entering the era of highly effective modulator therapiesKavita Dave, Rebecca Dobra, Sandra Scott, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|August 5, 2021
Incidence and risk factors of cancer in individuals with cystic fibrosis in the UK; a case-control studyOlga Archangelidi, Paul Cullinan, Nicholas J Simmonds, et al.
BMJ Open Respiratory Research|January 6, 2026
<u>Y</u>oga <u>O</u>utcomes <u>G</u>et <u>A</u>ssessed in <u>C</u>ystic <u>F</u>ibrosis (YOGA-CF): protocol of a multicentre interventional randomised controlled clinical trial-investigating effects of a 12-week yoga intervention for adults with cystic fibrosisGemma E Stanford, P Scarborough, Susan C Charman, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|September 8, 2022
Mediation of the total effect of cystic fibrosis-related diabetes on mortality: A UK Cystic Fibrosis Registry cohort studyKamaryn T Tanner, Rhian M Daniel, Diana Bilton, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 24, 2024
Bridging the gap: Challenging lung infections and clinical trial development in cystic fibrosisDamian G Downey, Nicholas J Simmonds, Silke van-Koningsbruggen-Rietschel, et al.
BMJ Open Respiratory Research|October 6, 2020
Investigating outcome measures for assessing airway clearance techniques in adults with cystic fibrosis: protocol of a single-centre randomised controlled crossover trialGemma Stanford, Jane C Davies, Omar Usmani, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 30, 2015
Response to Letter to the Editor: HbA1c as a screening tool for cystic fibrosis related diabetes: Response to letters by Widger et al. and Schnyder et alJuliana C Burgess, Nicola Bridges, Banya Winston, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 15, 2015
HbA1c as a screening tool for cystic fibrosis related diabetesJuliana C Burgess, Nicola Bridges, Winston Banya, et al.
Therapeutic Advances in Respiratory Disease|September 6, 2022
Clinimetric analysis of outcome measures for airway clearance in people with cystic fibrosis: a systematic reviewGemma E Stanford, Mandy Jones, Susan C Charman, et al.
Pageof 7

Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 14, 2025
"Mind the gap"- will we ever see equal median predicted survival for males and females in cystic fibrosis?Jamie Duckers, Sarah L Clarke, Susan C Charman, et al.
Pediatric Pulmonology|January 12, 2021
Entering the era of highly effective modulator therapiesKavita Dave, Rebecca Dobra, Sandra Scott, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|August 5, 2021
Incidence and risk factors of cancer in individuals with cystic fibrosis in the UK; a case-control studyOlga Archangelidi, Paul Cullinan, Nicholas J Simmonds, et al.
BMJ Open Respiratory Research|January 6, 2026
<u>Y</u>oga <u>O</u>utcomes <u>G</u>et <u>A</u>ssessed in <u>C</u>ystic <u>F</u>ibrosis (YOGA-CF): protocol of a multicentre interventional randomised controlled clinical trial-investigating effects of a 12-week yoga intervention for adults with cystic fibrosisGemma E Stanford, P Scarborough, Susan C Charman, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|September 8, 2022
Mediation of the total effect of cystic fibrosis-related diabetes on mortality: A UK Cystic Fibrosis Registry cohort studyKamaryn T Tanner, Rhian M Daniel, Diana Bilton, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 24, 2024
Bridging the gap: Challenging lung infections and clinical trial development in cystic fibrosisDamian G Downey, Nicholas J Simmonds, Silke van-Koningsbruggen-Rietschel, et al.
BMJ Open Respiratory Research|October 6, 2020
Investigating outcome measures for assessing airway clearance techniques in adults with cystic fibrosis: protocol of a single-centre randomised controlled crossover trialGemma Stanford, Jane C Davies, Omar Usmani, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 30, 2015
Response to Letter to the Editor: HbA1c as a screening tool for cystic fibrosis related diabetes: Response to letters by Widger et al. and Schnyder et alJuliana C Burgess, Nicola Bridges, Banya Winston, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 15, 2015
HbA1c as a screening tool for cystic fibrosis related diabetesJuliana C Burgess, Nicola Bridges, Winston Banya, et al.
Therapeutic Advances in Respiratory Disease|September 6, 2022
Clinimetric analysis of outcome measures for airway clearance in people with cystic fibrosis: a systematic reviewGemma E Stanford, Mandy Jones, Susan C Charman, et al.
Pageof 7